These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12205735)

  • 1. Renin-angiotensin-aldosterone system (RAAS) gene polymorphism as a risk factor of coronary in-stent restenosis.
    Ryu SK; Cho EY; Park HY; Im EK; Jang YS; Shin GJ; Shim WH; Cho SY
    Yonsei Med J; 2002 Aug; 43(4):461-72. PubMed ID: 12205735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
    Gross CM; Perrot A; Geier C; Posch MG; Hassfeld S; Kramer J; Schmidt S; Derer W; Dietz R; Ozcelik C
    J Invasive Cardiol; 2007 Jun; 19(6):261-4. PubMed ID: 17541127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of the rs1799752 polymorphism of the angiotensin-converting enzyme gene and the rs699 polymorphism of the angiotensinogen gene to the process of in-stent restenosis in a population of Polish patients with stable coronary artery disease.
    Osadnik T; Strzelczyk JK; Fronczek M; Bujak K; Reguła R; Gonera M; Gawlita M; Kurek A; Wasilewski J; Lekston A; Gierlotka M; Hawranek M; Ostrowska Z; Wiczkowski A; Poloński L; Gąsior M
    Adv Med Sci; 2016 Sep; 61(2):276-281. PubMed ID: 27162064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation.
    Ferrari M; Mudra H; Grip L; Voudris V; Schächinger V; de Jaegere P; Rieber J; Hausmann D; Rothman M; Koschyk DH; Figulla HR;
    Cardiology; 2002; 97(1):29-36. PubMed ID: 11893827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin-aldosterone system gene polymorphisms and coronary artery disease: detection of gene-gene and gene-environment interactions.
    Jia EZ; Xu ZX; Guo CY; Li L; Gu Y; Zhu TB; Wang LS; Cao KJ; Ma WZ; Yang ZJ
    Cell Physiol Biochem; 2012; 29(3-4):443-52. PubMed ID: 22508051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease.
    Lovati E; Richard A; Frey BM; Frey FJ; Ferrari P
    Kidney Int; 2001 Jul; 60(1):46-54. PubMed ID: 11422735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Polymorphisms of the Renin-Angiotensin-Aldosterone System as Risk Factors for the Development of In-Stent Restenosis in Patients with Stable Coronary Artery Disease.
    Azova M; Timizheva K; Ait Aissa A; Blagonravov M; Gigani O; Aghajanyan A; Tskhovrebova L
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34065198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between angiotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis: the role of angiotensin converting enzyme inhibitors in stent restenosis in patients with diabetes mellitus.
    Guneri S; Baris N; Aytekin D; Akdeniz B; Pekel N; Bozdemir V
    Int Heart J; 2005 Sep; 46(5):889-97. PubMed ID: 16272779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
    Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH
    J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of seven renin angiotensin system gene polymorphisms with restenosis in patients following coronary stenting.
    Zhu M; Yang M; Lin J; Zhu H; Lu Y; Wang B; Xue Y; Fang C; Tang L; Xu B; Jiang J; Chen X
    J Renin Angiotensin Aldosterone Syst; 2017 Jan; 18(1):1470320316688774. PubMed ID: 28196432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study of the I/D polymorphism and plasma angiotensin-converting enzyme (ACE) as risk factors for stent restenosis.
    Ribichini F; Ferrero V; Matullo G; Feola M; Vado A; Camilla T; Guarrera S; Carturan S; Vassanelli C; Uslenghi E; Piazza A
    Clin Sci (Lond); 2004 Oct; 107(4):381-9. PubMed ID: 15101817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of gene polymorphisms of the renin-angiotensin-aldosterone system on essential hypertension in Kazakhs in Xinjiang.
    Niu S; Zhang B; Zhang K; Zhu P; Li J; Sun Y; He N; Zhang M; Gao Z; Li X; Simayi A; Ge J; Cong M; Zhou W; Qiu C
    Clin Exp Hypertens; 2016; 38(1):63-70. PubMed ID: 26305278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene.
    Koch W; Mehilli J; von Beckerath N; Böttiger C; Schömig A; Kastrati A
    J Am Coll Cardiol; 2003 Jun; 41(11):1957-61. PubMed ID: 12798565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between ACE and AGT polymorphism and cardiovascular risk in acromegalic patients.
    Erbas T; Cinar N; Dagdelen S; Gedik A; Yorgun H; Canpolat U; Kabakci G; Alikasifoglu M
    Pituitary; 2017 Oct; 20(5):569-577. PubMed ID: 28712073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation.
    Canosi U; Angelica Merlini P; Bernardi F; Repetto A; Bramucci E; Ferrario M; Angoli L; Gnecchi M; Ferraresi P; Marchetti G; Tavazzi L; Ardissino D
    Thromb Haemost; 2004 Apr; 91(4):795-800. PubMed ID: 15045142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DD genotype of angiotensin converting enzyme polymorphism is a risk factor for coronary artery disease and coronary stent restenosis in Japanese patients.
    Taniguchi I; Yamazaki T; Wagatsuma K; Kurusu T; Shimazu Y; Takikawa K; Yoshikawa M; Kageyama S; Mochizuki S
    Jpn Circ J; 2001 Oct; 65(10):897-900. PubMed ID: 11665795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotypes of the angiotensin-converting enzyme (ACE) gene are associated with coronary artery disease but not with restenosis after coronary stenting.
    Martínez-Ríos MA; Alvarez-León E; Totomoch A; Angeles J; Peña-Duque MA; Delgadillo-Rodríguez H; Martínez-Rodríguez N; Ramírez-Fuentes S; Fragoso JM; Vargas-Alarcón G
    Exp Mol Pathol; 2014 Aug; 97(1):166-70. PubMed ID: 24995885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of angiotensinogen M253T gene polymorphism and an angiotensin converting enzyme inhibitor on restenosis after percutaneous coronary intervention.
    Toyofyuku M; Imazu M; Sumii K; Yamamoto H; Hayashi Y; Hiyama K; Kohno N
    Atherosclerosis; 2002 Feb; 160(2):339-44. PubMed ID: 11849656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin-aldosterone system related gene polymorphisms and urinary total arsenic is related to chronic kidney disease.
    Chen WJ; Huang YL; Shiue HS; Chen TW; Lin YF; Huang CY; Lin YC; Han BC; Hsueh YM
    Toxicol Appl Pharmacol; 2014 Sep; 279(2):95-102. PubMed ID: 24907556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting.
    Amant C; Bauters C; Bodart JC; Lablanche JM; Grollier G; Danchin N; Hamon M; Richard F; Helbecque N; McFadden EP; Amouyel P; Bertrand ME
    Circulation; 1997 Jul; 96(1):56-60. PubMed ID: 9236417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.